Marc van Beurden

7.1k citations

95 papers · 3.6k indexed · h-index 29

Impact in

Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Obstetrics and Gynecology top 1%
- Endometrial and Cervical Cancer Treatments

Papers in

Reproductive Medicine 19
- Ovarian cancer diagnosis and treatment 17
Epidemiology 39
- Cervical Cancer and HPV Research 31
- Nonmelanoma Skin Cancer Studies 12

Co-authors: Manon van Seters Neil K. Aaronson Anton J.M. de Craen Hester S. A. Oldenburg Saskia F. A. Duijts Theo J.M. Helmerhorst R.I. Olivier Claudia Heijmans‐Antonissen
Journals: Gynecologic Oncology (8 papers)International Journal of Cancer (7 papers)Climacteric (4 papers)Journal of Lower Genital Tract Disease (3 papers)Journal of Clinical Oncology (3 papers)
Partner nations: Netherlands United States United Kingdom

In The Last Decade

Marc van Beurden

93 papers receiving 3.5k citations

Peers

Countries citing papers authored by Marc van Beurden

Since Specialization

Citations

This map shows the geographic impact of Marc van Beurden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marc van Beurden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marc van Beurden more than expected).

Fields of papers citing papers by Marc van Beurden

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marc van Beurden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marc van Beurden. The network helps show where Marc van Beurden may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Marc van Beurden, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Marc van Beurden Line = papers co-authored together Marc van Beurden links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Diversity of the immune microenvironment and response to checkpoint inhibitor immunotherapy in mucosal melanoma JCI Insight ·Joris L. Vos, Joleen J.H. Traets, Xiaohang Qiao, Iris M. Seignette, Dennis Peters, Michel W.J.M. Wouters, Erik Hooijberg, Annegien Broeks, Jacqueline E. van der Wal, Barış Karakullukçu, W. Martin C. Klop, Arash Navran, Marc van Beurden, Oscar R. Brouwer, Luc G.T. Morris, Mariëtte I.E. van Poelgeest, Ellen Kapiteijn, John B.A.G. Haanen, Christian U. Blank, Charlotte L. Zuur	2024	5
2	High-grade serous carcinoma occurring after risk-reducing salpingo-oophorectomy in BRCA1/2 germline pathogenic variant carriers JNCI Journal of the National Cancer Institute ·Yu-Heng Qi, Franciele Soares Morlin, Harry Hollema, Marise M. Wagner, Qian Jianxiu, Helena C. van Doorn, Joanne A. de Hullu, Katja N. Gaarenstroom, Marc van Beurden, Luc R.C.W. van Lonkhuijzen, B.F.M. Slangen, Ronald P. Zweemer, E. Gómez, G. M. Baranova, Fenne L. Komdeur, 姜作培, Muriel A. Adank, Marijke R. Wevers, Maartje J. Hooning, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	2
3	The Paget Trial: topical 5% imiquimod cream for noninvasive vulvar Paget disease American Journal of Obstetrics and Gynecology ·M. van der Linden, Jinlong Tian, Marc van Beurden, Johan Bulten, Eleonora B. van Dorst, Rozanna Mulyani, K.A.P. Meeuwis, Dorry Boll, Rafael Bordini da Silva, Joanne A. de Hullu	2022	17
4	HPV-16 E6/E7 DNA tattoo vaccination using genetically optimized vaccines elicit clinical and immunological responses in patients with usual vulvar intraepithelial neoplasia (uVIN): a phase I/II clinical trial Journal for ImmunoTherapy of Cancer ·Noor A. M. Bakker, Jossie Rotman, Marc van Beurden, Henry Zijlmans, H. Köhler, Sanne Samuels, Bastiaan Nuijen, Jos H. Beijnen, Karin E. de Visser, John B.A.G. Haanen, Ton N. Schumacher, Tanja D. de Gruijl, Ekaterina S. Jordanova, Gemma G. Kenter, Joost H. van den Berg, Nienke E. van Trommel	2021	12
5	Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy Gynecologic Oncology ·Miranda P. Steenbeek, J Schlossmacher, Marline G. Harmsen, Nicoline Hoogerbrugge, Helena C. van Doorn, محمد صبري عبد الحميد إسماعيل, Marc van Beurden, Ronald P. Zweemer, Katja N. Gaarenstroom, 池尻好美, Nim. Ilham Nur Pratomo, M. Caroline Vos, Jurgen M.J. Piek, Luc R.C.W. van Lonkhuijzen, Mirjam J. A. Apperloo, S.F.P.J. Coppus, Joanna IntHout, Joanne A. de Hullu, Rosella Hermens	2021	2
6	Characteristics of Lynch Syndrome Associated Ovarian Cancer Obstetrical & Gynecological Survey ·О. Н. Ефремова, Geertruida H. de Bock, Joanne A. de Hullu, Harry Hollema, Ronald P. Zweemer, B.F.M. Slangen, Katja N. Gaarenstroom, Marc van Beurden, Helena C. van Doorn, Rolf H. Sijmons, Hans F. A. Vasen, Marian J.E. Mourits	2018	0
7	The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease JMIR Research Protocols ·M. van der Linden, K.A.P. Meeuwis, Denise Schuiten, E.B.L. van Dorst, Johan Bulten, Tjalling Bosse, Joanna IntHout, Dorry Boll, B.F.M. Slangen, Manon van Seters, Marc van Beurden, Mariëtte I.E. van Poelgeest, Joanne A. de Hullu	2017	16
8	A Prospective Assessment of Surgical Risk Factors in 114 Gluteal Fold Flap Reconstructions After Oncological Vulvoperineal Resection Annals of Plastic Surgery ·Xueying Li, J. Joris Hage, Marc van Beurden	2017	7
9	Hormone replacement therapy after risk-reducing salpingo-oophorectomy minimises endocrine and sexual problems: A prospective study European Journal of Cancer ·Victor Powers, Marc van Beurden, Jacobien M. Kieffer, Eveline M. A. Bleiker, Heiðdís Valdimarsdóttir, Leon F.A.G. Massuger, Marian J.E. Mourits, Katja N. Gaarenstroom, E.B.L. van Dorst, H.W.H.M. van der Putten, Neil K. Aaronson	2017	33
10	Lichen Sclerosus: Incidence and Risk of Vulvar Squamous Cell Carcinoma Cancer Epidemiology Biomarkers & Prevention ·Maaike C.G. Bleeker, R Nevare Mahendra, Lucy Overbeek, Marc van Beurden, Johannes Berkhof	2016	166
11	Optical coherence tomography accurately identifies patients with penile (pre) malignant lesions: A single center prospective study Urology Annals ·Т. Е. Денискова, Daniël M. de Bruin, Dirk J. Faber, Simon Horenblas, Charles A. Schauer, Roxana Paola Palacios Cartagena, Marc van Beurden, Ton G. van Leeuwen, Arzu Kaplanoglu	2015	5
12	Cost-effectiveness of cognitive behavioral therapy and physical exercise for alleviating treatment-induced menopausal symptoms in breast cancer patients Journal of Cancer Survivorship ·Janne C. Mewes, Lotte Steuten, Saskia F. A. Duijts, Hester S. A. Oldenburg, Marc van Beurden, Martijn M. Stuiver, Myra S. Hunter, Jacobien M. Kieffer, Wim H. van Harten, Neil K. Aaronson	2014	31
13	Cost-Effectiveness Of Cognitive-Behavioral Therapy And Physical Exercise For Alleviating Treatment-Induced Menopausal Symptoms In Breast Cancer Patients Value in Health ·Janne C. Mewes, Lotte Steuten, Saskia F. A. Duijts, Yu. A. Litvinenko, Marc van Beurden, Martijn M. Stuiver, Myra S. Hunter, Jacobien M. Kieffer, Wim H. van Harten, Neil K. Aaronson	2013	2
14	An Autoimmune Phenotype in Vulvar Lichen Sclerosus and Lichen Planus: A Th1 Response and High Levels of MicroRNA-155 Journal of Investigative Dermatology ·Annelinde Terlou, Lindy A.M. Santegoets, W I van der Meijden, Claudia Heijmans‐Antonissen, Sigrid M. A. Swagemakers, Peter J. van der Spek, Patricia C. Ewing, Marc van Beurden, Theo J.M. Helmerhorst, Leen J. Blok	2011	111
15	Characteristics of breast cancer patients who experience menopausal transition due to treatment Climacteric ·Saskia F. A. Duijts, Renato Barahona Arévalo, Hester S. A. Oldenburg, Marc van Beurden, Neil K. Aaronson	2011	5
16	Premalignant epithelial disorders of the vulva: squamous vulvar intraepithelial neoplasia, vulvar Paget's disease and melanoma in situ Acta Obstetricia Et Gynecologica Scandinavica ·Annelinde Terlou, Leen J. Blok, Theo J.M. Helmerhorst, Marc van Beurden	2010	22
17	No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study British Journal of Cancer ·Brenda Hermsen, R.I. Olivier, René H.M. Verheijen, Marc van Beurden, Joanne A. de Hullu, Leon F.A.G. Massuger, Curt W. Burger, Cecile T.M. Brekelmans, M J E Mourits, Geertruida H. de Bock, Katja N. Gaarenstroom, Hester H. van Boven, Thea M. Mooij, Matti A. Rookus	2007	104
18	Serous Borderline Tumor of the Ovary Presenting With Cervical Lymph Node Involvement The American Journal of Surgical Pathology ·Aliakbar Bazyari, Eduarda Garcia Sanches, Frank R.W. van de Goot, Marc van Beurden, Josephine C. Dorsman, P. J. van Diest	2006	17
19	In the absence of (early) invasive carcinoma, vulvar intraepithelial neoplasia associated with lichen sclerosus is mainly of undifferentiated type: new insights in histology and aetiology Journal of Clinical Pathology ·Manon van Seters, F. J. W. ten Kate, Marc van Beurden, René H.M. Verheijen, Chris J.L.M. Meijer, Matthé P.M. Burger, Theo J.M. Helmerhorst	2006	24
20	The accuracy of hysterosalpingography in the diagnosis of tubal pathology: a meta-analysis Fertility and Sterility ·Patricia Swart, Ben W. Mol, R. G. Yeo, Marc van Beurden, Ken Redekop, Patrick M. Bossuyt	1995	214

About Marc van Beurden

Marc van Beurden is a scholar working on Reproductive Medicine, Epidemiology, Urology, Dermatology and Surgery, having authored 95 papers that have together received 3.6k indexed citations. Recurring topics across this work include Genital Health and Disease (32 papers), Cervical Cancer and HPV Research (31 papers), Ovarian cancer diagnosis and treatment (17 papers), BRCA gene mutations in cancer (15 papers), Nonmelanoma Skin Cancer Studies (12 papers), Cancer survivorship and care (11 papers), Urologic and reproductive health conditions (11 papers) and Menopause: Health Impacts and Treatments (10 papers). The work is most often cited by research in Reproductive Medicine (899 citations), Obstetrics and Gynecology (513 citations), Dermatology (346 citations), Urology (246 citations) and Epidemiology (1.1k citations). Marc van Beurden has collaborated with scholars based in Netherlands, United States and United Kingdom. Frequent co-authors include Manon van Seters, Neil K. Aaronson, Anton J.M. de Craen, Hester S. A. Oldenburg, Saskia F. A. Duijts, Theo J.M. Helmerhorst, R.I. Olivier, Claudia Heijmans‐Antonissen, Maaike C.G. Bleeker and Johannes Berkhof. Their work appears in journals such as Gynecologic Oncology, International Journal of Cancer, Climacteric, Journal of Lower Genital Tract Disease and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact